# US 2010/0305436 A1 · Systems, devices, and methods for photoactive assisted resection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0305436 A1
- Document ID: US20100305436A1
- Status: Published application
- Kind: A1
- Application number: 12/678,123
- Filed: 2008-09-12
- Published: 2010-12-02
- Earliest claimed: 2007-09-14
- Assignees: Light Sciences Oncology, Inc.
- Inventors: James C. Chen; Llew Keltner
- Web page: https://patentgrep.com/patent/US20100305436A1

## CPC

- A61B 5/0059: {using light, e.g. diagnosis by transillumination, diascopy, fluorescence (photoacoustic A61B5/0093; optical measurement of heart rate A61B5/02416; optical measurement of blood flow A61B5/0261; optical measurement of analytes A61B5/1455)}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61B 90/30: Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B 90/35: Supports therefor
- A61B 90/20: Surgical microscopes characterised by non-optical aspects
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method and system is used to locate tissue for removal during a resection. The system includes a container that holds a photoactivatable agent capable of binding with unwanted tissue at a treatment site, a light source, and a viewing device. The light source is adapted to continuously output light that causes fluorescence of the photoactivatable agent in unwanted tissue. The system provides fluorescence-enhanced viewing of the treatment site through the viewing device. The viewing device has a filter that filters out light from the light source that is reflected from the treatment site while allowing a fluorescence emission from the photoactivatable agent to pass therethrough to each eye of the user. The light from the light source and the fluorescence emission are in different regions of the energy spectrum.

## Claims

### Claim 1

A system for viewing targeted tissue at a treatment site, comprising:
a photoactivatable agent adapted to accumulate in targeted tissue;
a light source adapted to output an excitation wavelength that causes the photoactivatable agent to produce a fluorescence emission, the fluorescence emission having a fluorescence wavelength different from the excitation wavelength so as to allow separation of the excitation wavelength and the fluorescence wavelength; and
a direct-viewing device for observing the treatment site therethrough, the direct-viewing device including a filter adapted to separate the excitation wavelength and the fluorescence wavelength by filtering out the excitation wavelength from the light source that is reflected from the treatment site while allowing the fluorescence wavelength from the photoactivatable agent to pass therethrough to the eyes of a user to increase contrast between the targeted tissue and non-targeted tissue as the light source outputs light.

### Claim 2 (depends on 1)

The system of claim 1, wherein the photoactivatable agent is capable of preferentially accumulating in the targeted tissue.

### Claim 3 (depends on 1)

The system of claim 1, wherein the light source is capable of emitting at least one of coherent light or non-coherent light.

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The system of claim 1, wherein the direct-viewing device has imaging optics configured to provide three-dimensional viewing of the treatment site.

### Claim 6 (depends on 5)

The system according to claim 5, wherein the imaging optics are adapted to magnify an image of the treatment site viewed through the direct-viewing device.

### Claim 7 (depends on 1)

The system of claim 1, wherein the direct-viewing device includes eyewear.

### Claim 8 (depends on 1)

The system of claim 1, wherein the direct-viewing device includes at least one loupe.

### Claim 9 (depends on 1)

The system of claim 1, wherein the direct-viewing device includes a surgical telescope.

### Claim 10 (depends on 1)

The system of claim 1, wherein the direct-viewing device includes a surgical microscope.

### Claim 11 (depends on 1)

The system of claim 1, wherein the filter comprises a bandpass filter or a longpass filter.

### Claim 12 (depends on 1)

The system of claim 1, wherein the filter is a clip-on filter adapted to couple to a microscope and/or eyewear or the filter is adapted to threadably mate with a portion of a microscope.

### Claim 13 (depends on 1)

The system of claim 1, wherein the light source is adapted to continuously output the excitation wavelength that causes the photoactivatable agent to produce a continuous fluorescence emission.

### Claim 14 (depends on 1)

The system of claim 1, wherein the photoactivatable agent is capable of emitting red light when exited by blue light.

### Claim 15

A resection kit for performing surgery, comprising:
instructions for use; and
packaging capable of holding the instructions for use and a system for viewing targeted tissue at a treatment site, the system comprising:
a photoactivatable agent adapted to accumulate in targeted tissue a photoactivatable agent adapted to accumulate in targeted tissue:
a light source adapted to output an excitation wavelength that causes the photoactivatable agent to produce a fluorescence emission, the fluorescence emission having a fluorescence wavelength different from the excitation wavelength so as to allow separation of the excitation wavelength and the fluorescence wavelength; and
a direct-viewing device for observing the treatment site therethrough, the direct-viewing device including a filter adapted to separate the excitation wavelength and the fluorescence wavelength by filtering out the excitation wavelength from the light source that is reflected from the treatment site while allowing the fluorescence wavelength from the photoactivatable agent to pass therethrough to both eyes of a user to increase contrast between the targeted tissue and non-targeted tissue as the light source outputs light

### Claim 16 (depends on 15)

The resection kit of claim 15, further comprising:
at least one surgical tool configured to remove cancerous tissue identified by viewing through the direct-viewing device.

### Claim 17

A system for viewing tissue at a surgical site, comprising:
a photoactivatable agent for activation by an excitation wavelength; and
an external viewing device through which a user is capable of observing the surgical site, the viewing device including a passive filter that transmits light emitted by the photoactivatable agent and that filters out the excitation wavelength to enable direct-viewing and fluorescence-enhanced optical differentiation of targeted tissue and other tissue at the surgical site.

### Claim 18 (depends on 17)

The system of claim 17, wherein the viewing device further includes imaging optics configured to magnify an image of the surgical site and to allow rays of light from the surgical site to pass therethrough to the user's eyes.

### Claim 19 (depends on 17)

The system according to claim 17, wherein the external viewing device is adapted to provide an analog image of the surgical site.

### Claim 20 (depends on 17)

The system according to claim 17, wherein the external viewing device includes wearable goggles or a clip for coupling to a microscope.

### Claim 21 (depends on 17)

The system according to claim 17, further comprising a light source carried by the viewing device.

### Claim 22 (depends on 17)

The system according to claim 17, further comprising a resection tool carrying a light source adapted to cause fluorescence of the photoactivatable agent.

### Claim 23 (depends on 17)

The system according to claim 17, further comprising a resection tool carrying a filter.

### Claim 24

A surgical kit comprising:
instructions for use; and
packaging holding a system for viewing tissue at a surgical site, the system comprising:
a photoactivatable agent for activation by an excitation wavelength; and
an external viewing device through which a user is capable of observing the surgical site, the viewing device including a passive filter that transmits light emitted by the photoactivatable agent and that filters out the excitation wavelength to enable direct-viewing and fluorescence-enhanced optical differentiation of targeted tissue and other tissue at the surgical site.

### Claim 25

A system for viewing tissue at a surgical site, comprising:
a photoactivatable agent capable of fluorescing; and
a filter that transmits light emitted by the photoactivatable agent while filtering out other light to increase a relative amount of the light outputted by the photoactivatable agent delivered to the user for true fluorescence-enhanced viewing of the surgical site enabling optical differentiation of targeted tissue for removal and other tissue at the surgical site.

### Claim 26 (depends on 25)

The system of claim 25, further comprising a resection tool that carries the filter.

### Claim 27 (depends on 25)

The system of claim 25, wherein the filter is adapted to threadably mate with a portion of a microscope.

### Claim 28 (depends on 25)

The system of claim 25, wherein the filter is a clip-on filter adapted to couple to a microscope and/or eyewear.

### Claim 29

A method of viewing targeted tissue at a treatment site, comprising;
delivering a photoactivatable agent to the treatment site of a subject;
exposing the photoactivatable agent at the treatment site to an excitation wavelength from an energizable light source to cause fluorescence of the photoactivatable agent at the treatment site;
directly viewing a fluorescence-enhanced image of the treatment site by looking through a viewing device, the viewing device including a filter adapted to filter out the excitation wavelength from the energizable light source reflected from the treatment site while allowing fluorescence to pass therethrough to the user; and
identifying targeted tissue at the treatment site based at least in part on directly viewing of the fluorescence-enhanced image.

### Claim 30 (depends on 29)

The method of claim 29, wherein the energizable light source comprises at least one light-emitting diode positioned external to the subject.

### Claim 31 (depends on 29)

The method according to claim 29, wherein exposing the photoactivatable agent at the treatment site to light comprises continuously emitting light.

### Claim 32 (depends on 29)

The method according to claim 29, wherein directly viewing the fluorescence-enhanced image includes viewing the fluorescence-enhanced image with both eyes.

### Claim 33 (depends on 29)

The method according to claim 29, wherein identifying targeted tissue includes locating margins of cancerous tissue by comparing visual differences between the cancerous tissue and non-cancerous tissue.

### Claim 34 (depends on 29)

The method according to claim 29, further comprising removing cancerous tissue at the treatment site based, at least in part, on the identification of targeted tissue.

### Claim 35 (depends on 29)

The method according to claim 29, further comprising accumulating the photoactivatable agent in cancerous tissue such that a concentration of the photoactivatable agent in the cancerous tissue is greater than a concentration of the photoactivatable agent in non-cancerous tissue.

### Claim 36 (depends on 29)

The method according to claim 29, wherein the photoactivatable agent is configured to selectively accumulate in cancerous tissue.

### Claim 37 (depends on 36)

The method according to claim 36, further comprising allowing sufficient time to pass for photoactivatable agent that is not accumulated to the cancerous tissue to clear from the treatment site prior to identifying the targeted tissue.

### Claim 38 (depends on 29)

The method according to claim 29, wherein the fluorescence-enhanced image increases visualization of the fluorescence from the photoactivatable agent as compared to viewing by a naked eye.

### Claim 39 (depends on 29)

The system according to claim 29, wherein the light source is adapted to output mostly blue light that causes the photoactivatable agent to output red light.

### Claim 40 (depends on 29)

The system according to claim 29, wherein the photoactivatable agent comprises talaporfin sodium.

### Claim 41 (depends on 1)

The system according to claim 1, wherein the filter comprises a first filter for the user's right eye and a second filter for the user's left eye.

### Claim 42 (depends on 41)

The system according to claim 41, wherein the first filter is coupleable to a first loupe and the second filter is coupleable to a second loupe.

### Claim 43 (depends on 1)

The system according to claim 1, wherein the filter is configured to filter out the excitation wavelength continuously emitted from the light source and reflected from the treatment site while allowing the fluorescence wavelength from the photoactivatable agent to produce continuous fluorescence-enhanced optical differentiation of the targeted tissue and other tissue at the surgical site.
